Kennedy Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-404
Closed -$234K 146
2025
Q4
$234K Buy
+404
New +$228K 0.09% 124
2025
Q2
Sell
-419
Closed -$209K 138
2025
Q1
$209K Sell
419
-14
-3% -$7.58K 0.1% 120
2024
Q4
$225K Hold
433
0.1% 114
2024
Q3
$268K Sell
433
-23
-5% -$13.6K 0.12% 109
2024
Q2
$252K Sell
456
-35
-7% -$20.1K 0.13% 106
2024
Q1
$285K Sell
491
-720
-59% -$404K 0.15% 99
2023
Q4
$643K Sell
1,211
-3,104
-72% -$1.5M 0.36% 73
2023
Q3
$2.18M Sell
4,315
-1,643
-28% -$876K 1.31% 21
2023
Q2
$3.11M Buy
5,958
+434
+8% +$234K 1.82% 14
2023
Q1
$3.18M Sell
5,524
-121
-2% -$68.2K 1.95% 14
2022
Q4
$3.11M Buy
+5,645
New +$2.99M 1.98% 14

Other funds holding TMO

Kennedy Investment Group's TMO Position: Q1 2026 in Review

Kennedy Investment Group sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 404 shares — an estimated $234K sold.

Kennedy Investment Group first reported a position in TMO in Q4 2022 and held it in 11 quarters. The position peaked at $3.18M in Q1 2023. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Kennedy Investment Group reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Kennedy Investment Group sold 404 Thermo Fisher Scientific shares in Q1 2026, an estimated $234K.
  • Kennedy Investment Group first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 11 quarters.
  • Kennedy Investment Group's Thermo Fisher Scientific position peaked at $3.18M in Q1 2023.
  • 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Kennedy Investment Group's 13F filing for Q1 2026, filed 22 Apr 2026.